# Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection

> **NCT02223611** · PHASE2 · UNKNOWN · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Stage Ⅱ
- Non-small Cell Lung Cancer Stage ⅢA

## Interventions

- **DRUG:** S1 capsule
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT02223611
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2018-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02223611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02223611, "Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT02223611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*